Eisai And Biogen Say Canada's Drug Agency Issued Final Positive Recommendation Supporting Public Reimbursement Of Leqembi For Early Alzheimer's Disease

뉴스 본문을 불러오고 있어요.

Eisai And Biogen Say Canada's Drug Agency Issued Final Positive Recommendation Supporting Public Reimbursement Of Leqembi For Early Alzheimer's Disease | 웨이프 WAPE

Eisai And Biogen Say Canada's Drug Agency Issued Final Positive Recommendation Supporting Public Reimbursement Of Leqembi For Early Alzheimer's Disease

기사 요약

관련 종목

댓글 —